1. Home
  2. SWBI vs ARVN Comparison

SWBI vs ARVN Comparison

Compare SWBI & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smith & Wesson Brands Inc.

SWBI

Smith & Wesson Brands Inc.

HOLD

Current Price

$15.21

Market Cap

688.3M

Sector

Industrials

ML Signal

HOLD

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$8.96

Market Cap

658.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SWBI
ARVN
Founded
1852
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Ordnance And Accessories
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
688.3M
658.2M
IPO Year
2000
2018

Fundamental Metrics

Financial Performance
Metric
SWBI
ARVN
Price
$15.21
$8.96
Analyst Decision
Strong Buy
Buy
Analyst Count
1
19
Target Price
$14.00
$15.05
AVG Volume (30 Days)
386.4K
854.3K
Earning Date
06-17-2026
05-04-2026
Dividend Yield
3.37%
N/A
EPS Growth
N/A
58.84
EPS
0.05
N/A
Revenue
$474,661,000.00
$262,600,000.00
Revenue This Year
$7.61
N/A
Revenue Next Year
$3.72
N/A
P/E Ratio
$309.90
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.73
$6.06
52 Week High
$15.79
$14.22

Technical Indicators

Market Signals
Indicator
SWBI
ARVN
Relative Strength Index (RSI) 54.53 35.45
Support Level $13.90 $7.35
Resistance Level $15.24 $10.18
Average True Range (ATR) 0.42 0.51
MACD 0.01 -0.03
Stochastic Oscillator 68.48 23.34

Price Performance

Historical Comparison
SWBI
ARVN

About SWBI Smith & Wesson Brands Inc.

Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

Share on Social Networks: